Med Ad News’ Post

Why is patient centricity so crucial to market access strategies? In the April issue of PharmaTimes Media Ltd, Avalere's Senior Director, Brigit Kyei-Baffour, MBA, explains the importance of listening to and learning from patients throughout the drug life cycle. By doing so, companies can ensure that the therapies they bring to market are not only innovative but also accessible and aligned with real-world data points on patient needs.   Check out 'The Human League' article on page 32: https://bit.ly/4aacKMg   #Avalere #AvalereHealth #MarketAccess #patientcentricity

In the intricate tapestry of healthcare decision-making, post-market drug evaluation acts as a vital thread, weaving together evidence and insights, adaptability, collaboration, and, most importantly, patient-centricity. Let's continue to champion and prioritize these evaluations, embracing their transformative power in shaping a healthier, more resilient future for all. #CoLab CADTH #HealthcareInnovation #PatientSafety #DrugEvaluation #HealthcareDecisionMaking #DataDrivenHealthcare

COVID and social distancing forced the pharma companies to change the way in which they promoted their products, engaging with Healthcare Professionals through remote forms of communication. On 12th April 2024, 12pm (GMT) join Wendy and Samantha for Life Science Law’s live webinar, where we will delve into the principles and issues in this digital era. Register here now to secure your place. https://lnkd.in/djcc2fiW   Remember, knowledge is amplified when shared. Please do tag or mention colleagues who shouldn't miss this!   #Healthcare #Webinar #PharmaceuticalIndustry #LegalInsight

This new service looks like a well intended repository to me with some good graphics and flow diagrams to simplify existing regulations and guidance. However…… There is still a long way to go in harmonising NHS standards and compliance between International Standards (ISO 14971 & ISO 27001) to make the transition easier for medical device manufacturers. Where possible, when we support clients at 8foldGovernance we try to harmonise documentation to prevent duplication and territorial silos of policies and procedures. In addition, I am not sure if the service sign posts developers to the risks of crossing into a stand alone regulatory activity - which the CQC discuss in their own regulated activity guidance.  I have discussed this is a blog previously published - https://lnkd.in/dbKvEzXa Hopefully this is just the start of a very useful resource! #jointhe8fold

As our article continues to gain traction even a year after publication, the topic is still of interest, and our practical experience and solutions shared are still relevant. The impact of the Blueprint is encouraging, resulting in improved local evidence plans, established evidence teams, enhanced RWD use and strategic implementation of patient-centric science in local affiliates. It is essential to establish specific x-functional value teams that target local evidence needs and opportunities for external impact with a cross-functionally aligned approach, such as field communications, reimbursement dossiers, guideline development, and policy shaping. https://lnkd.in/eHGXZHsT #realworlddata #realworldevidence #rwe #rwd #data #healthcare #biopharma #medicalaffairs

Demystifying the Maze of Drug Data: Unveil Clarity with Nano Health Suite's IDDK Tired of struggling with inaccurate or incomplete drug information? Feeling overwhelmed by the ever-expanding world of global medications? Introducing Nano Health Suite's IDDK (International Drug Data Knowledge), your gateway to reliable, comprehensive, and up-to-date drug data from around the world! IDDK empowers you with: Global Reach: Access drug information from across the globe, in 30+ languages! Unwavering Accuracy: Stay informed with continuous content curation and quality checks. Effortless Search: Find the specific information you need with advanced search and filtering tools. Personalized Insights: Generate tailored reports and receive drug safety alerts for informed decisions. Always Evolving: Stay ahead of the curve with regular updates and new features. IDDK is more than just a database; it's your trusted knowledge partner, supporting better healthcare decisions, improved patient outcomes, and enhanced compliance. Ready to unlock the power of IDDK? Contact Nano Health Suite today for a free consultation and see how we can help you navigate the world of drug data with confidence! #healthcareIT #drugdata #IDDK #NanoHealthSuite #KnowledgeEmpowers #GlobalHealthcare

We spend much time in health comms looking at verbal messaging, claims, referencing... but so often we overlook the visual aspects that arguably communicate more meaning. Based on recent semiotic research by 11 LONDON into how patients and HCPs are depicted in pharma comms versus in wider popular culture, this webinar picks up on historical highlights and emergent trends which can help inform the way we use visuals in our materials. Please DM me or email my colleague max.lee@11-london.com to book a space. #pharmamarketing #pharma #healthcarecomms #patientcentricity #patientengagement

At #DPHARM2024, PA's experts engaged with clinical innovators to explore how we can accelerate the pace of #ClinicalTrials. Discover the insights that are pushing boundaries and redefining industry benchmarks! https://bit.ly/4gOrILZ

Read this insightful “First Opinion” editorial in STAT by DarioHealth’s Chief Medical Officer Dr. Omar Manejwala on the pitfalls of digital health companies pretending to be prescription medicines. Dr. Manejwala outlines how some digital health companies have failed to heed the lesson that technology should influence health behaviors—without being prescribed. This makes digital therapeutics easier, more equitable, and more affordable. Read his editorial here: https://bit.ly/4cpLYAw #DigitalHealth #HealthTech #Innovation

We are thrilled to announce our participation in the AHIP 2024 Conference! We are excited about the agenda and look forward to engaging in discussions around enhancing the affordability of prescription drugs, boosting home-based care, leveraging AI and technology, and rebuilding public trust in healthcare systems. Here’s a quick summary of what we do at zakipoint Health: ✔️ Boosting member enrollment and engagement through automated campaigns ✔️ Steering members and closing gaps in care through data-driven campaigns ✔️ Providing case managers with consolidated reports to facilitate quicker decision-making through comprehensive access to clinical and claims data ✔️ Leveraging price transparency to help members make better decisions How can we help you? ✔️ The power of actionable analytics ✔️ Strategies to engage your members effectively ✔️ Ways to achieve significant cost savings We would love to connect with you and discuss how we can support your goals!